Trials / Withdrawn
WithdrawnNCT00447863
Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women
An Open-Label, Single-Dose, Randomized, 2-Period, Crossover, Bioequivalence Study to Compare Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg in 2 Dosage Forms With Different Dissolution Characteristics in Healthy, Cycling Women
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
Levonorgestrel/ethinyl estradiol (LNG/EE) is an investigational drug that is being developed as an oral contraceptive (birth control pill). The purpose of this trial is to compare different preparations of LNG/EE by assessing the way they are absorbed into the blood.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levonorgestrel/Ethinyl Estradiol |
Timeline
- Start date
- 2007-08-01
- Completion
- 2007-08-01
- First posted
- 2007-03-15
- Last updated
- 2021-08-20
Source: ClinicalTrials.gov record NCT00447863. Inclusion in this directory is not an endorsement.